Home
/
Q32 Bio Inc.
/
Financials
/
Quarterly
Q32 Bio Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Q32 Bio Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2024
$0
Nov 7, 2024
Q2
2024
Jun 30, 2024
$0
Aug 8, 2024
Q1
2024
Mar 31, 2024
$0
May 9, 2024
Q3
2024
Sep 30, 2023
$1.86M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$3.21M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$2.95M
May 9, 2024
Q1
2018
Mar 31, 2018
$823.4K
May 14, 2018
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2023
Sep 30, 2023
$0
Nov 14, 2023
Q2
2023
Jun 30, 2023
$354.0K
Aug 14, 2023
Q1
2023
Mar 31, 2023
$802.0K
May 11, 2023
Q3
2023
Sep 30, 2022
$802.0K
Nov 14, 2023
Q2
2023
Jun 30, 2022
$802.0K
Aug 14, 2023
Q1
2023
Mar 31, 2022
$802.0K
May 11, 2023
Q3
2022
Sep 30, 2021
$1.68M
Nov 10, 2022
Q2
2022
Jun 30, 2021
$2.19M
Aug 15, 2022
Q1
2022
Mar 31, 2021
$29.31M
May 16, 2022
Q3
2021
Sep 30, 2020
$567.0K
Nov 15, 2021
Q2
2021
Jun 30, 2020
$567.0K
Aug 12, 2021
Q1
2021
Mar 31, 2020
$588.0K
May 6, 2021
Q3
2020
Sep 30, 2019
$441.0K
Nov 9, 2020
Q2
2020
Jun 30, 2019
$392.0K
Aug 10, 2020
Q1
2020
Mar 31, 2019
$270.0K
May 7, 2020
Q1
2019
Dec 31, 2018
$5.32M
May 13, 2019
Q2
2019
Dec 31, 2018
$5.32M
Aug 8, 2019
Q3
2019
Dec 31, 2018
$5.32M
Nov 12, 2019
Q3
2019
Sep 30, 2018
$1.60M
Nov 12, 2019
Q2
2019
Jun 30, 2018
$1.40M
Aug 8, 2019
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($7.39M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($9.49M)
Aug 6, 2025
Q3
2025
Jun 30, 2025
($9.49M)
Nov 13, 2025
Q3
2025
May 19, 2025
$500.0K
Nov 13, 2025
Q2
2025
Mar 31, 2025
($11.03M)
Aug 6, 2025
Q3
2025
Mar 31, 2025
($11.03M)
Nov 13, 2025
Q1
2025
Mar 31, 2025
($11.03M)
May 8, 2025
Q3
2025
Sep 30, 2024
($17.60M)
Nov 13, 2025
Q3
2025
Jun 30, 2024
($16.98M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($16.98M)
Aug 6, 2025
Q1
2025
Mar 31, 2024
$1.03M
May 8, 2025
Q2
2025
Mar 31, 2024
$1.03M
Aug 6, 2025
Q3
2025
Mar 31, 2024
$1.03M
Nov 13, 2025
Q3
2024
Sep 30, 2023
($14.03M)
Nov 7, 2024
Q3
2024
Jun 30, 2023
($5.81M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($5.81M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($6.84M)
May 9, 2024
Q2
2024
Mar 31, 2023
($6.84M)
Aug 8, 2024
Q3
2024
Mar 31, 2023
($6.84M)
Nov 7, 2024
Q3
2023
Sep 30, 2022
($33.73M)
Nov 14, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($7.58M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($9.17M)
Aug 6, 2025
Q1
2025
Mar 31, 2025
($12.23M)
May 8, 2025
Q3
2025
Sep 30, 2024
($18.81M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($17.92M)
Aug 6, 2025
Q1
2025
Mar 31, 2024
($14.84M)
May 8, 2025
Q3
2024
Sep 30, 2023
($7.80M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($7.28M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($7.37M)
May 9, 2024
Q3
2023
Sep 30, 2022
($32.86M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($28.31M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($37.62M)
May 11, 2023
Q3
2022
Sep 30, 2021
($30.66M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($30.55M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($1.11M)
May 16, 2022
Q3
2021
Sep 30, 2020
($28.27M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($35.70M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($36.49M)
May 6, 2021
Q3
2020
Sep 30, 2019
($31.29M)
Nov 9, 2020
Q2
2020
Jun 30, 2019
($27.97M)
Aug 10, 2020